Members | Market | Warrants | Research | A.I. | Education | AASTOCKS | Products | US Stocks
Back to Home  
Member Service| Live Picks| Top Features| Back Test| Market| Tech Analysis| University| About Tradetrek
Block Trades | Money Flow | VWAP | Fundamentals | Historical chart walker | Back Test | Stock Code Lookup
Stock ID: Quote Chart News Fundamentals Comment 5-day Forecast 6-month Target
 
Dec 28, 2025   01:33:08 p.m.
Print  Forward
2009-5-27   09:26:00 a.m. HKT, XFNA
DJ MARKET TALK: CS Tips Weak 2Q09 For China Pharmaceutical Sector
 
0914 [Dow Jones] Credit Suisse expects weak 2Q09 for China pharmaceutical sector, with April data already indicating slower sales growth, especially for chemical drugs. Notes slowdown due to destocking by hospitals amid uncertainties about new Essential Drug List and related price cuts; lagging effect of economic downturn. "China's pharmaceutical sector in general outperformed the major indices recently, and we believe it is time to turn cautious, at least for the near term," says Credit Suisse. Keeps sector at Market Weight. Within sector, Shandong Weigao (8199.HK) ended down 4.0% at HK$19.88 Tuesday, China Pharmaceutical (1093.HK) down 0.5% at HK$4.30.(SUT) Contact us in Singapore. 65 64154 140; MarketTalk@dowjones.com Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http://www.djnewsplus.com/access/al?rnd=wJWAFJMYr5Jg95OYuRK2YQ%3D%3D. You can use this link on the day this article is published and the following day. (Delayed by 1 hour) -0- Copyright (c) 2009 Dow Jones & Company, Inc.
 

News Provided by XFNA
 

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved
 
 

Disclaimers | Privacy Policy | Career Opportunities | Contact Us | Help
www.aastocks.com
Support Hotline:(852)2186 8685/ (852) 2121 8803
Email: support@aastocks.com
Copyright 2000 AASTOCKS.com Ltd. All rights reserved.
AASTOCKS.com LIMITED is a SFC registered Investment Advisor.
Note: AASTOCKS.com Ltd endeavors to ensure the accuracy and reliability of the information provided but does not guarantee its accuracy or reliability and accepts no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.